J. Martineau

Evaluation of a continuous quality improvement program in anticoagulant therapy

L. Lalonde, C. Leblanc, Ariane Cantin, 2016, Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC.

Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting

S. Kahn, M. Blostein, S. Schulman, 2012, Thrombosis and Haemostasis.

Reliability, Validity and Ease of Use of a Portable Point-of-Care Coagulation Device in a Pharmacist-Managed Anticoagulation Clinic

M. Vanier, L. Lalonde, N. Blais, 2002, Journal of Thrombosis and Thrombolysis.

Primary care practices and determinants of optimal anticoagulation management in a collaborative care model.

M. Vanier, L. Blais, D. Berbiche, 2010, American heart journal.

Dosage of enoxaparin among obese and renal impairment patients.

L. Lalonde, N. Blais, K. Almanric, 2005, Thrombosis research.

Pharmacoeconomic Analysis of Fondaparinux Versus Enoxaparin for the Prevention of Thromboembolic Events in Orthopedic Surgery Patients

G. Dranitsaris, S. Kahn, Jeffrey S. Ginsberg, 2004, American journal of cardiovascular drugs : drugs, devices, and other interventions.

Is long-term pharmacist-managed anticoagulation service efficient? A pragmatic randomized controlled trial.

M. Vanier, L. Blais, D. Berbiche, 2008, American heart journal.

Development of Quality Indicators to Assess Oral Anticoagulant Management in Community Pharmacies for Patients with Atrial Fibrillation

L. Guénette, S. Perreault, L. Lalonde, 2018, Journal of managed care & specialty pharmacy.